8-K: CareTrust REIT Reports Record Fourth Quarter and Full Year 2024 Results, Eyes Continued Growth in 2025

CareTrust REIT announces strong Q4 and full-year 2024 results, driven by strategic investments and solid operational performance, while also providing guidance for continued growth in 2025.

Summary

• CareTrust REIT reported net income of $52.1 million, or $0.29 per diluted share, for the fourth quarter of 2024.
• Normalized FFO for the quarter was $72.9 million, or $0.40 per diluted share, and normalized FAD was $74.3 million, or $0.41 per diluted share.
• For the full year 2024, net income was $125.1 million, or $0.80 per diluted share.
• Full year normalized FFO reached $232.9 million, or $1.50 per diluted share, and normalized FAD was $238.8 million, or $1.54 per diluted share.
• The company invested $696.5 million during the quarter at an estimated stabilized yield of 9.9%.
• CareTrust upsized its revolving credit line to $1.2 billion and extended the maturity to February 2029.
• The company collected 98.8% of contractual rent and interest during the quarter.
• Net Debt to Annualized Normalized Run Rate EBITDA stood at 0.5x.
• Since quarter end, CareTrust has invested approximately $26.8 million at an estimated stabilized yield of 10.6% and has an investment pipeline of approximately $325 million.
• CareTrust entered into a new $750.0 million ATM Program and has approximately $205 million in cash on hand.
• The company is providing 2025 guidance, projecting net income of approximately $1.35 to $1.39 per diluted share, normalized FFO of approximately $1.68 to $1.72 per diluted share, and normalized FAD of approximately $1.72 to $1.76 per diluted share.
• The 2025 guidance assumes a diluted weighted-average common share count of 187.5 million shares and estimated 2.5% CPI-based rent escalators under long-term net leases.

Sentiment

Score: 9

Explanation: The document presents a highly positive outlook with record financial results, strategic investments, strong balance sheet, and optimistic guidance for 2025. The management's comments further reinforce this positive sentiment.

Positives

• The company achieved record financial results for both the quarter and the year.
• CareTrust REIT has a strong balance sheet with low leverage (0.5x Net Debt to Annualized Normalized Run Rate EBITDA).
• The company has significant liquidity with $205 million in cash and a $1.2 billion revolving credit line.
• CareTrust REIT has a robust investment pipeline of $325 million.
• The company has a high rent collection rate of 98.8%.
• CareTrust REIT has an investment grade credit rating on its unsecured notes.
• The company has a high historical investment yield of 9.3%.

Negatives

• The company recognized $5.353 million in impairment of real estate investments for the quarter ended December 31, 2024.
• The company recognized $4.9 million in provision for loan losses, net for the quarter ended December 31, 2024.

Risks

• The ability and willingness of tenants and borrowers to meet their obligations.
• Potential for additional impairment charges related to assets held for sale.
• Impact of healthcare reform legislation on tenants and borrowers.
• Tenants' ability to comply with applicable laws and regulations.
• Tenants' willingness to renew leases.
• Availability of suitable acquisition opportunities and tenants.
• Ability to generate sufficient cash flows to service debt.
• Access to debt and equity capital markets.
• Fluctuating interest rates.
• Impact of public health crises.
• Ability to retain key management personnel.
• Ability to maintain REIT status.
• Changes in U.S. tax law.
• Risks inherent in the real estate business, including environmental matters and illiquidity.

Future Outlook

The company projects for 2025, net income of approximately $1.35 to $1.39 per diluted share, normalized FFO of approximately $1.68 to $1.72 per diluted share, and normalized FAD of approximately $1.72 to $1.76 per diluted share.

Management Comments

• CareTrust's President and Chief Executive Officer, Dave Sedgwick, commented, 'We finished a record year with a record quarter. Now all eyes are on 2025 and beyond.'
• Mr. Sedgwick continued, 'We continue to position the company to build on the momentum of impactful growth with top-tier operators. Our balance sheet, access to capital, team, partnerships, and opportunities to grow and diversify the portfolio are all in a stronger position than they were twelve months ago.'

Industry Context

CareTrust REIT's focus on skilled nursing and seniors housing aligns with the growing demand for healthcare-related real estate due to the aging population. The company's strategic investments and operator partnerships position it well to capitalize on these trends.

Comparison to Industry Standards

• CareTrust's Net Debt to Annualized Normalized Run Rate EBITDA of 0.5x is significantly lower than the typical range of 4.0x to 5.0x for REITs, indicating a conservative capital structure.
• The company's dividend payout ratio of approximately 71% on normalized FAD is within a reasonable range for REITs, balancing shareholder returns with reinvestment in growth opportunities.
• CareTrust's historical investment yield of 9.3% is competitive within the healthcare REIT sector, reflecting its ability to source and execute accretive deals.
• Compared to peers like Omega Healthcare Investors (OHI) and National Health Investors (NHI), CareTrust's focus on smaller, regional operators provides diversification and potentially higher yields, but also requires more active asset management.

Stakeholder Impact

• Shareholders can expect continued dividend payments and potential for capital appreciation.
• Employees benefit from the company's growth and financial stability.
• Tenants gain access to capital and operational support.
• The company's investments contribute to the availability of quality healthcare facilities for seniors.

Next Steps

• CareTrust's management will discuss fourth quarter and full year 2024 results, recent developments and other matters on a conference call on February 13, 2025.
• The company will continue to pursue accretive investment opportunities, leveraging its strong balance sheet and access to capital.

Key Dates